Potential protective effects of naringenin against vancomycin-induced nephrotoxicity via reduction on apoptotic and oxidative stress markers in rats

References

• Ahmida, M.H., 2012. Protective role of curcumin in nephrotoxic oxidative damage induced by vancomycin in rats. Experimental and Toxicologic Pathology, 64 (3), 149–153.
   PubMedGoogle Scholar
• Al-Dosari, D.I., 2017. Flavonoid naringenin attenuates oxidative stress, apoptosis and improves neurotrophic effects in the diabetic rat retina. Nutrients, 9 (10), 1161.
   Web of Science ®Google Scholar
• Al-Rejaie, S.S., et al., 2013. Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World Journal of Gastroenterology, 19 (34), 5633–5644.
   PubMed Web of Science ®Google Scholar
• Arimura, Y., et al., 2012. Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis. Free Radical Biology & Medicine, 52 (9), 1865–1873.
   PubMed Web of Science ®Google Scholar
• Badary, O.A., et al., 2005. Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sciences, 76 (18), 2125–2135.
   PubMed Web of Science ®Google Scholar
• Basarslan, F., et al., 2012. Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats. Human & Experimental Toxicology, 31 (7), 726–733.
   PubMed Web of Science ®Google Scholar
• Bektur, N.E., et al., 2016. Protective effects of silymarin against acetaminophen-induced hepatotoxicity and nephrotoxicity in mice. Toxicology and Industrial Health, 32 (4), 589–600.
   PubMed Web of Science ®Google Scholar
• Canacankatan, N., et al., 2012. Affirmative effects of iloprost on apoptosis during ischemia-reperfusion injury in kidney as a distant organ. Renal Failure, 34 (1), 111–118.
   PubMed Web of Science ®Google Scholar
• Cetin, H., et al., 2007. Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model. Clinical and Experimental Pharmacology and Physiology, 34 (11), 1181–1185.
   PubMed Web of Science ®Google Scholar
• Dalaklioglu, S., et al., 2010. Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury. Toxicology Letters, 192 (2), 91–96.
   PubMed Web of Science ®Google Scholar
• Elsherbiny, N.M., et al., 2017. Renal protective effects of thymoquinone against sodium nitrite-induced chronic toxicity in rats: impact on inflammation and apoptosis. Life Sciences, 180, 1–8.
   PubMed Web of Science ®Google Scholar
• Fouad, A.A., et al., 2014. Protective effect of naringenin against gentamicin-induced nephrotoxicity in rats. Environmental Toxicology and Pharmacology, 38 (2), 420–429.
   PubMed Web of Science ®Google Scholar
• Gnanasoundari, M., and Pari, L., 2006. Impact of naringenin on oxytetracycline-mediated oxidative damage in kidney of rats. Renal Failure, 28 (7), 599–605.
   PubMed Web of Science ®Google Scholar
• Habib, S., and Ali, A., 2011. Biochemistry of nitric oxide. Indian Journal of Clinical Biochemistry, 26 (1), 3–17.
   PubMedGoogle Scholar
• Havasi, A., and Borkan, S.C., 2011. Apoptosis and acute kidney injury. Kidney International, 80 (1), 29–40.
   PubMed Web of Science ®Google Scholar
• Hermenean, A., et al., 2013. Protective effects of naringenin on carbon tetrachloride-induced acute nephrotoxicity in mouse kidney. Chemico-Biological Interactions, 205 (2), 138–147.
   PubMed Web of Science ®Google Scholar
• Humanes, B., et al., 2015. Protective effects of cilastatin against vancomycin-induced nephrotoxicity. Biomed Research International, 2015, 1.
   Google Scholar
• Im, D.S., et al., 2017. Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein. Toxicology Letters, 277, 9–17.
   PubMed Web of Science ®Google Scholar
• Jain, A., et al., 2011. Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats. Ecotoxicology and Environmental Safety, 74 (4), 607–614.
   PubMed Web of Science ®Google Scholar
• Kapoor, R., and Kakkar, P., 2014. Naringenin accords hepatoprotection from streptozotocin induced diabetes in vivo by modulating mitochondrial dysfunction and apoptotic signaling cascade. Toxicology Report, 1, 569–581.
   PubMedGoogle Scholar
• Kara, S., et al., 2014. Protective effect of hesperetin and naringenin against apoptosis in ischemia/reperfusion-induced retinal injury in rats. The Scientific World Journal, 2014, 1.
   Google Scholar
• Kim, C.S., et al., 2016. Nicotine-induced apoptosis in human renal proximal tubular epithelial cells. PLoS One, 11 (3), e0152591.
   PubMed Web of Science ®Google Scholar
• Kocyigit, A., et al., 2016. Cytotoxic, genotoxic and apoptotic effects of naringenin-oxime relative to naringenin on normal and cancer cell lines. Asian Pacific Journal of Tropical Biomedicine, 6 (10), 872–880.
   Web of Science ®Google Scholar
• Konishi, H., et al., 2013. Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats. Journal of Chemotherapy (Florence, Italy), 25 (5), 273–278.
   PubMed Web of Science ®Google Scholar
• Lowry, O.H., et al., 1951. Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry, 193 (1), 265–275.
   PubMed Web of Science ®Google Scholar
• Mershiba, S.D., Dassprakash, M.V., and Saraswathy, S.D., 2013. Protective effect of naringenin on hepatic and renal dysfunction and oxidative stress in arsenic intoxicated rats. Molecular Biology Reports, 40 (5), 3681–3691.
   PubMed Web of Science ®Google Scholar
• Nishino, Y., et al., 2002. Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat. Redox Report, 7 (5), 317–319.
   PubMed Web of Science ®Google Scholar
• Nishino, Y., et al., 2003. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radical Research, 37 (4), 373–379.
   PubMed Web of Science ®Google Scholar
• Ocak, S., et al., 2007. Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats. Basic & Clinical Pharmacology & Toxicology, 100 (5), 328–333.
   PubMed Web of Science ®Google Scholar
• Ohkawa, H., Ohishi, N., and Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95 (2), 351–358.
   PubMed Web of Science ®Google Scholar
• Öktem, F., et al., 2005. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology, 215 (3), 227–233.
   PubMed Web of Science ®Google Scholar
• Renugadevi, J., and Prabu, S.M., 2009. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology, 256 (1–2), 128–134.
   PubMed Web of Science ®Google Scholar
• Roy, S., et al., 2016. Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-b1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events. Pharmaceutical Biology, 54 (9), 1616–1627.
   PubMed Web of Science ®Google Scholar
• Sahu, B.D., et al., 2014. Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection. Toxicology and Applied Pharmacology, 277 (1), 8–20.
   PubMed Web of Science ®Google Scholar
• Sak, K., 2014. Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacognosy Reviews, 8 (16), 122–146.
   PubMedGoogle Scholar
• Sanchez-Gonzalez, P.D., et al., 2011. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrology, Dialysis, Transplantation, 26 (11), 3484–3495.
   PubMed Web of Science ®Google Scholar
• Servais, H., et al., 2008. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis, 13 (1), 11–32.
   PubMed Web of Science ®Google Scholar
• Wang, K., et al., 2017. Naringenin prevents ischaemic stroke damage via anti-apoptotic and anti-oxidant effects. Clinical and Experimental Pharmacology and Physiology, 44 (8), 862–871.
   PubMed Web of Science ®Google Scholar